This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schiltz, R L Articles by Rushlow, K E Search for Related Content PubMed PubMed Citation Articles by Schiltz, R L Articles by Rushlow, K E

Equine infectious anemia virus gene expression: characterization of the RNA splicing pattern and the protein products encoded by open reading frames S1 and S2.

Department of Biochemistry, Louisiana State University, Baton Rouge 70803.

ABSTRACT

The utilization of predicted splice donor and acceptor sites in generating equine infectious anemia virus (EIAV) transcripts in fetal donkey dermal cells (FDD) was examined. A single splice donor site identified immediately upstream of the gag coding region joins the viral leader sequence to all downstream exons of spliced EIAV transcripts. The predominant 3.5-kb transcript synthesized in EIAV-infected FDD cells appears to be generated by a single splicing event which links the leader sequence to the first of two functional splice acceptor sites near the 5' end of the S1 open reading frame (ORF). The translation products encoded by the 3.5-kb transcript were examined by producing in vitro transcripts from a cDNA corresponding to this RNA followed by in vitro translation in wheat germ extracts. These transcripts directed the synthesis of three proteins: the virus trans-activator protein (EIAV Tat) encoded by ORF S1, a protein of unknown function encoded by ORF S2, and the virus envelope glycoprotein. When transfected into FDD cells, this cDNA also directed expression of EIAV Tat. Amino-terminal sequence analysis of the in vitro-synthesized S1 protein supports the suggestion that translation of EIAV Tat is initiated at a CUG codon within the virus leader region. Both in vitro-synthesized S2 protein and synthetic peptides corresponding to S2 are shown to react positively with sera obtained from EIAV-infected horses, providing the first direct evidence of expression of this protein in infected animals.

This article has been cited by other articles:

• Jin, S., Issel, C. J., Montelaro, R. C. (2004). Serological Method Using Recombinant S2 Protein To Differentiate Equine Infectious Anemia Virus (EIAV)-Infected and EIAV-Vaccinated Horses. CVI 11: 1120-1129 [Abstract] [Full Text]  
• Yoon, S., Kingsman, S. M., Kingsman, A. J., Wilson, S. A., Mitrophanous, K. A. (2000). Characterization of the equine infectious anaemia virus S2 protein. J. Gen. Virol. 81: 2189-2194 [Abstract] [Full Text]  
• Li, F., Leroux, C., Craigo, J. K., Cook, S. J., Issel, C. J., Montelaro, R. C. (2000). The S2 Gene of Equine Infectious Anemia Virus Is a Highly Conserved Determinant of Viral Replication and Virulence Properties in Experimentally Infected Ponies. J. Virol. 74: 573-579 [Abstract] [Full Text]  
• Li, F., Puffer, B. A., Montelaro, R. C. (1998). The S2 Gene of Equine Infectious Anemia Virus Is Dispensable for Viral Replication In Vitro. J. Virol. 72: 8344-8348 [Abstract] [Full Text]  
• Cook, R. F., Leroux, C., Cook, S. J., Berger, S. L., Lichtenstein, D. L., Ghabrial, N. N., Montelaro, R. C., Issel, C. J. (1998). Development and Characterization of an In Vivo Pathogenic Molecular Clone of Equine Infectious Anemia Virus. J. Virol. 72: 1383-1393 [Abstract] [Full Text]